Status:
COMPLETED
Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI
Lead Sponsor:
Thomas Erb
Conditions:
Upper Respiratory Infections
Eligibility:
All Genders
25-84 years
Phase:
PHASE4
Brief Summary
To describe respiratory and laryngeal responses to laryngeal stimulation during propofol anesthesia in children with upper airway infections. To determine whether the co-administration of remifentanil...
Detailed Description
Patients undergoing anesthesia in the presence of an upper respiratory infection (URI) are very common in pediatric anesthesia practice. Although, clinical data confirm that children with URIs are at ...
Eligibility Criteria
Inclusion
- ASA I + II
- elective intervention under general anesthesia
- acute upper respiratory tract infection
Exclusion
- chronic respiratory tract infection
- fever \>38,3° celsius
- productive cough
- neuromuscular disease
- malignant hyperthermia
- cardiac disease
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00611195
Start Date
January 1 2008
End Date
December 1 2012
Last Update
October 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University children's hospital
Basel, Switzerland, 4058